1. Home
  2. FTEK vs INKT Comparison

FTEK vs INKT Comparison

Compare FTEK & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fuel Tech Inc.

FTEK

Fuel Tech Inc.

HOLD

Current Price

$1.69

Market Cap

48.4M

Sector

Industrials

ML Signal

HOLD

Logo MiNK Therapeutics Inc.

INKT

MiNK Therapeutics Inc.

HOLD

Current Price

$12.15

Market Cap

59.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTEK
INKT
Founded
1987
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Pollution Control Equipment
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.4M
59.4M
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
FTEK
INKT
Price
$1.69
$12.15
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$35.00
AVG Volume (30 Days)
172.8K
6.8K
Earning Date
05-05-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$30,467,000.00
N/A
Revenue This Year
$14.17
N/A
Revenue Next Year
$11.62
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.17
$8.48
52 Week High
$3.64
$16.80

Technical Indicators

Market Signals
Indicator
FTEK
INKT
Relative Strength Index (RSI) 66.38 57.76
Support Level $1.37 $10.79
Resistance Level $1.69 $13.00
Average True Range (ATR) 0.08 0.58
MACD 0.03 0.02
Stochastic Oscillator 86.49 88.03

Price Performance

Historical Comparison
FTEK
INKT

About FTEK Fuel Tech Inc.

Fuel Tech Inc is a technology provider of boiler optimization, efficiency improvement, and air pollution reduction to utility and industrial customers. The company operates in two segments, Air Pollution Control and Fuel Chem. The Air Pollution Control technology segment includes technologies to reduce NOx emissions in flue gas from boilers, incinerators, furnaces, and other stationary combustion sources. The Fuel Chem technology segment uses chemical processes in combination with Computational Fluid Dynamics and Chemical Kinetics Modeling for boiler modeling for the control of slagging, fouling, corrosion, opacity and other sulfur trioxide-related issues in furnaces and boilers through the addition of chemicals into the furnace using TIFI Targeted In-Furnace Injection technology.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development and manufacturing of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. iNKT cells offer distinct therapeutic advantages as a platform for allogeneic therapy in that the cells naturally home to tissues, aid clearance of tumors and infected cells, and suppress graft-versus-host-disease. Its product candidate, agenT-797, is an off-the-shelf, allogeneic, native iNKT cell therapy. It operates its business in single segment.

Share on Social Networks: